Myeloma Mai Yawa Tare da Plasmacytoma Mai Sauƙi

Wannan shine lamarin wani majiyyaci namiji mai shekaru 73 da aka gano yana da cutar myeloma mai yawa, wanda ya rikitarwa sakamakon kasancewar plasmacytoma na extramedullary. A duk tsawon lokacin da ake amfani da Dara-VRD (Daratumumab, Bortezomib, Lenalidomide, Dexamethasone), plasmacytoma na extramedullary ya ci gaba, yana haifar da ciwo mai yawa da rashin jin daɗi ga majiyyaci.

Idan aka yi la'akari da yanayin cutar mai tsanani da kuma rashin mayar da martani ga magungunan gargajiya, an shigar da majiyyacin cikin gwajin asibiti don maganin ƙwayoyin BCMA CAR-T. Bayan an ɗauki matakan shirye-shiryen da suka wajaba, gami da ɓarnar lymph, majiyyacin ya sami jiko na ƙwayoyin BCMA CAR-T.

Abin mamaki, cikin kwanaki 10 bayan allurar, majiyyacin ya fuskanci martanin cytokine release syndrome (CRS) na mataki na biyu, wanda ke nuna ƙarfin aikin garkuwar jiki. Bugu da ƙari, akwai CRS mai mahimmanci a wurin da aka gano plasmacytoma na extramedullary.

Abin da ya fi ban mamaki shi ne a cikin wannan ɗan gajeren lokaci, raunin extramedullary da a da ba ya jure wa magani, wanda ya tabbatar da juriya ga nau'ikan chemotherapy da yawa, magungunan da aka yi niyya, da kuma ƙwayoyin rigakafi na monoclonal, ya ɓace gaba ɗaya. Majinyacin ya sami cikakkiyar gafara, wanda ke nuna nasarar maganin.

A duk tsawon lokacin da ake yin maganin, ƙungiyar likitocin ta sa ido sosai kan majiyyacin don ganin ko akwai wata alama ta rashin lafiya, sannan ta ba da cikakken kulawa ta tallafi. Wannan ya haɗa da kula da alamun CRS da kuma magance duk wata matsala da ta shafi magani.

Yayin da maganin ke ci gaba, ƙungiyar likitoci ta ci gaba da sa ido sosai kan martanin da majiyyacin ke bayarwa ga maganin ƙwayoyin BCMA CAR-T. An gudanar da gwaje-gwaje akai-akai don tantance ingancin maganin da kuma magance duk wani illa da ke tasowa nan take.

Bayan nasarar da aka samu ta hanyar samun cikakkiyar sassauci, yanayin rayuwar majiyyaci ya inganta sosai, tare da rage radadi da rashin jin daɗi da ke tattare da plasmacytoma na extramedullary. Da yake an shawo kan cutar, majiyyacin ya sami damar ci gaba da ayyukan yau da kullun kuma ya ji daɗin ingantacciyar lafiya gaba ɗaya.

Bugu da ƙari, bayan mun fahimci muhimmancin kulawa ta dogon lokaci, ƙungiyar likitocinmu ta ci gaba da shiga cikin tafiyar majinyacin bayan magani. An tsara alƙawarin bibiya akai-akai don sa ido kan yanayin majinyacin, tantance juriyar amsawar magani, da kuma magance duk wani mummunan sakamako da ka iya sake dawowa ko kuma sakamakon da ka iya biyo baya a makare.

Baya ga bin diddigin lafiya, cibiyarmu ta samar da cikakkun ayyukan tallafi don taimaka wa majiyyaci ya daidaita rayuwarsa bayan magani. Wannan ya haɗa da samun damar ba da shawara, shirye-shiryen gyara hali, da albarkatun ilimi don taimaka wa majiyyaci da iyalansa su shawo kan waɗanda suka tsira da kuma kula da rayuwa mai kyau.

Nasarar da aka samu a wannan shari'ar ba wai kawai ta nuna ingancin maganin ƙwayoyin BCMA CAR-T wajen magance cutar myeloma mai saurin kamuwa da cuta ba, har ma ta nuna mahimmancin kulawa ta musamman da ta fannoni daban-daban wajen kula da cututtukan da ke da sarkakiya a fannin jini. Alƙawarinmu na samar da tallafi da kulawa mai dorewa yana nuna sadaukarwarmu ga tabbatar da mafi kyawun sakamako ga marasa lafiyarmu bayan matakin magani.

Kafin & watanni 3 bayan allurar